InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: locicat1 post# 3574

Wednesday, 09/13/2017 2:36:13 PM

Wednesday, September 13, 2017 2:36:13 PM

Post# of 18220
Any explanation from anyone regarding the lack of any progress in OVER FOUR years following two separate meetings in 2013 with the FDA seeking approval to move forward on Phase 2 studies with (a) LDN for Crohn's Disease and with (b) methionine enkephalin (MENK) in pancreatic cancer. No explanations??